These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 24346824)

  • 1. Montelukast: a novel therapeutic option in eosinophilic peritonitis.
    Forbes TA; Lunn AJ
    Pediatr Nephrol; 2014 Jul; 29(7):1279-82. PubMed ID: 24346824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eosinophilic oesophagitis: a novel treatment using Montelukast.
    Attwood SE; Lewis CJ; Bronder CS; Morris CD; Armstrong GR; Whittam J
    Gut; 2003 Feb; 52(2):181-5. PubMed ID: 12524397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eosinophilic gastroenteritis in a young girl--long term remission under Montelukast.
    Quack I; Sellin L; Buchner NJ; Theegarten D; Rump LC; Henning BF
    BMC Gastroenterol; 2005 Jul; 5():24. PubMed ID: 16026609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Montelukast as a treatment modality for eosinophilic gastroenteritis.
    De Maeyer N; Kochuyt AM; Van Moerkercke W; Hiele M
    Acta Gastroenterol Belg; 2011 Dec; 74(4):570-5. PubMed ID: 22319970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of montelukast as steroid-sparing agent for recurrent eosinophilic gastroenteritis.
    Schwartz DA; Pardi DS; Murray JA
    Dig Dis Sci; 2001 Aug; 46(8):1787-90. PubMed ID: 11508684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful use of montelukast in eosinophilic gastroenteritis: a case report and a literature review.
    El-Alali EA; Abukhiran IM; Alhmoud TZ
    BMC Gastroenterol; 2021 Jul; 21(1):279. PubMed ID: 34238222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic Hotline: Cysteinyl leukotriene receptor antagonist montelukast in the treatment of atopic dermatitis.
    Broshtilova V; Gantcheva M
    Dermatol Ther; 2010; 23(1):90-3. PubMed ID: 20136913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of eosinophilic gastroenteritis with montelukast.
    Neustrom MR; Friesen C
    J Allergy Clin Immunol; 1999 Aug; 104(2 Pt 1):506. PubMed ID: 10452782
    [No Abstract]   [Full Text] [Related]  

  • 9. Montelukast in pediatric asthma management.
    Walia M; Lodha R; Kabra SK
    Indian J Pediatr; 2006 Apr; 73(4):275-82. PubMed ID: 16816486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eosinophilic oesophagitis: treatment using Montelukast.
    Sinharay R
    Gut; 2003 Aug; 52(8):1228-9. PubMed ID: 12865292
    [No Abstract]   [Full Text] [Related]  

  • 11. Montelukast reduces peripheral blood eosinophilia but not tissue eosinophilia or symptoms in a patient with eosinophilic gastroenteritis and esophageal stricture.
    Daikh BE; Ryan CK; Schwartz RH
    Ann Allergy Asthma Immunol; 2003 Jan; 90(1):23-7. PubMed ID: 12546333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eosinophilic cystitis: successful long-term treatment with montelukast sodium.
    Sterrett S; Morton J; Perry D; Donovan J
    Urology; 2006 Feb; 67(2):423.e19-423.e21. PubMed ID: 16461108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Montelukast: use in pediatric patients with eosinophilic gastrointestinal disease.
    Vanderhoof JA; Young RJ; Hanner TL; Kettlehut B
    J Pediatr Gastroenterol Nutr; 2003 Feb; 36(2):293-4. PubMed ID: 12548071
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical efficacy and pharmacokinetics of montelukast in dyspeptic children with duodenal eosinophilia.
    Friesen CA; Kearns GL; Andre L; Neustrom M; Roberts CC; Abdel-Rahman SM
    J Pediatr Gastroenterol Nutr; 2004 Mar; 38(3):343-51. PubMed ID: 15076638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of severe atopic dermatitis with cysteinyl leukotriene receptor antagonist montelukast.
    Angelova-Fischer I; Tsankov N
    Acta Dermatovenerol Alp Pannonica Adriat; 2005 Sep; 14(3):115-9. PubMed ID: 16200338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Leukotriene Receptor Antagonist Montelukast Reduces Alpha-Synuclein Load and Restores Memory in an Animal Model of Dementia with Lewy Bodies.
    Marschallinger J; Altendorfer B; Rockenstein E; Holztrattner M; Garnweidner-Raith J; Pillichshammer N; Leister I; Hutter-Paier B; Strempfl K; Unger MS; Chishty M; Felder T; Johnson M; Attems J; Masliah E; Aigner L
    Neurotherapeutics; 2020 Jul; 17(3):1061-1074. PubMed ID: 32072462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leukotriene receptor antagonism with montelukast as a possible therapeutic for venous thromboembolism prophylaxis: An observational study.
    Sutton SS; Magagnoli J; Cummings TH; Hardin JW
    Prostaglandins Other Lipid Mediat; 2022 Aug; 161():106649. PubMed ID: 35595009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malabsorption syndrome and leukotriene inhibitor.
    Selva Kumar C; Das RR; Balakrishnan CD; Balagurunathan K; Chaudhuri K
    J Trop Pediatr; 2011 Apr; 57(2):135-7. PubMed ID: 20571153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-inflammatory effects of montelukast in mild cystic fibrosis.
    Schmitt-Grohé S; Eickmeier O; Schubert R; Bez C; Zielen S
    Ann Allergy Asthma Immunol; 2002 Dec; 89(6):599-605. PubMed ID: 12487226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years.
    Knorr B; Franchi LM; Bisgaard H; Vermeulen JH; LeSouef P; Santanello N; Michele TM; Reiss TF; Nguyen HH; Bratton DL
    Pediatrics; 2001 Sep; 108(3):E48. PubMed ID: 11533366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.